Table 2.
General features | Plasmid DNA | MiniDNA* |
---|---|---|
Replicative in bacterial host | Non-replicative in bacterial host | |
Supercoiled | Supercoiled or circular/linear closed | |
Bacterial origin of replication | No bacterial origin of replication | |
Bacterial selection marker (Antibiotic resistance gene) | No bacterial selection marker (Antibiotic resistance gene) | |
Relatively high immunostimulatory unmethylated CpG dinucleotides** | No to very few immunostimulatory unmethylated CpG dinucleotides | |
Large-scaled production is available | Large-scaled production is available | |
Pharmaceutical-grade purification is available | Pharmaceutical-grade purification is available | |
Medium to large size*** | Relatively smaller than plasmids |
Bacterial sequence depleted.
Depends to the size.
Depends to the size of therapeutic transgene.